Mobia Medical, Inc. (NASDAQ:MOBI) Stock Has Average Price Target of $20.75

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have been given a consensus rating of “Moderate Buy” by the seven analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average 12 month target price among brokers that have covered the stock in the last year is $20.75.

Several research firms have recently commented on MOBI. Weiss Ratings assumed coverage on shares of Mobia Medical in a research report on Wednesday, August 12th. They set a “sell (e-)” rating for the company. Wall Street Zen upgraded shares of Mobia Medical from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. BTIG Research reaffirmed a “buy” rating and issued a $19.00 price target on shares of Mobia Medical in a research report on Wednesday, August 12th. Finally, JPMorgan Chase & Co. raised their price target on shares of Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th.

Insider Buying and Selling

In related news, Director Casey Tansey acquired 16,441 shares of the stock in a transaction dated Tuesday, August 18th. The stock was purchased at an average cost of $12.07 per share, with a total value of $198,442.87. Following the completion of the purchase, the director directly owned 318,332 shares in the company, valued at $3,842,267.24. This trade represents a 5.45% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last three months, insiders purchased 87,000 shares of company stock worth $1,016,367.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Readystate Asset Management LP bought a new stake in Mobia Medical during the second quarter worth $134,000. Citadel Advisors LLC purchased a new stake in Mobia Medical in the 2nd quarter valued at $670,000. Finally, State Street Corp purchased a new stake in Mobia Medical in the 2nd quarter valued at $735,000.

Mobia Medical Stock Performance

Shares of MOBI stock opened at $8.63 on Monday. The company has a market cap of $287.30 million and a price-to-earnings ratio of -0.43. The company’s fifty day simple moving average is $10.65. The company has a quick ratio of 12.80, a current ratio of 13.28 and a debt-to-equity ratio of 0.04. Mobia Medical has a 12 month low of $8.29 and a 12 month high of $15.29.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($1.10) earnings per share for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The business had revenue of $13.51 million for the quarter. The business’s revenue for the quarter was up 102.4% on a year-over-year basis. On average, equities analysts predict that Mobia Medical will post -2.63 earnings per share for the current fiscal year.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.